More Than a Model: Putting AI to Work in Medical Devices and Therapeutics

For 67 veterans, one November day offered a chance to reflect on decades of service, remember those who did not come home and experience a long-deserved expression of gratitude.

PFAS risk for pharmaceutical manufacturers doesn't just come from regulations - and informed companies can't afford to ignore the other sources. In this blog, explore the four PFAS pressures to watch and learn how to start building a defensible strategy.

Why do promising transportation technologies succeed in pilots but struggle to gain widespread adoption? The answer goes far beyond the technology itself. Discover the hidden barriers between proving what works and creating the conditions needed to move next-generation mobility from successful demonstrations to lasting impact.

PFAS regulations are evolving fast, and medical device manufacturers can't afford to wait and see. In this blog, find out what's new in 2026 and how to prioritize action where it matters most.

Pharmaceutical manufacturers often know where they intentionally use PFAS, but far fewer can say where all the PFAS entering and leaving their facilities actually come from. In this blog, learn why PFAS exposure is a mass-balance challenge and what it takes to map it.